Abeona Therapeutics Inc
F:PCJP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abeona Therapeutics Inc
F:PCJP
|
US |
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
F
|
Federal National Mortgage Association
SWB:FNM
|
US |
|
S
|
Schlumberger NV
XHAM:SCL
|
US |
|
S
|
Swiss Re AG
XBER:SR9
|
CH |
Wall St Price Targets
PCJP Price Targets Summary
Abeona Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for PCJP is 0.3078 EUR with a low forecast of 0.2164 EUR and a high forecast of 0.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCJP's stock price target?
Price Target
0.3078
EUR
According to Wall Street analysts, the average 1-year price target for PCJP is 0.3078 EUR with a low forecast of 0.2164 EUR and a high forecast of 0.45 EUR.
What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
71%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 71%.
What is the Gross Profit forecast for Abeona Therapeutics Inc?
Projected CAGR
280%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 280%.
What is the Pre-Tax Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-22%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.
What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 8 years is 18%.
